Information For Authors

  • Manuscripts submitted to DNA and Cell Biology may not be under consideration for publication elsewhere.

Submitting Manuscripts

Please be sure to follow the Instructions for Authors below on Preparation of Manuscript.

All manuscripts should be submitted via our online system: http://mc.manuscriptcentral.com/dna  

Manuscripts should be in one of the following areas of Cell Biology and Molecular Biology.

  • Molecular Genetics/Genomics/Epigenetics will be covered from extracellular signaling to intracellular cascades, nuclear translocation of transcription factors, alterations in epigenetic markings, splicing and export of mRNA, microRNA silencing, and mRNA sequestration or translation.
  • Protein expression/modification/regulation including protein half-life and degradation, targeting to specific organelles or secretion will be topics suitable for manuscripts.
  • Organelles/Autophagy/Apoptosis will cover molecular and cell biology of the ER, peroxisomes, mitochondria, endosomes and the nuclear and plasma membranes.
  • Inflammation and host cellular responses to infection by viruses or responses to a pathogen’s secreted products, and evasive strategies of pathogens to host pathways are topics for the journal.
  • Molecular Mechanisms of Disease will focus on molecular and cellular contributions to human disease.

Among the types of manuscripts that will be considered for peer-reviewed publication are:  Research papers (both long and brief), Reviews, Science policy opinion essays, meeting reports, and olbituaries. Another type of manuscript is the DNACB Bit, a by-invitation short review.

In order to assure originality, the editors may use Cross-check’s iThenticateTM software on any manuscript submitted for publication.  Those documents with a high score will be rejected.

For submission of Manuscripts online, the corresponding author will need:

  • Cover letter
  • List of at least 3 potential reviewers.  [NOTE: Only suggested reviewers who have an academic and/or institutional email address will be considered.  Email addresses with generic domain names (Gmail, Hotmail, Yahoo, AOL, etc) will be disregarded.]
  • List of scientists who are inappropriate as reviewers – stating the specific reason(s)
  • Individual manuscript files including:
             o   Main file containing text only (no figures or tables).  This file should contain a title page
                  with all authors and their affiliations, and it should also contain the abstract (see below
                  for further information)
             o   An Acknowledgement including a list of all funding sources
             o   A statement indicating the specific role in the study of each individual who is a co-author
             o   Separate figure files in either .tif or .eps format
             o   Separate table files, including table titles and table footnotes (if applicable), preferably
                  in  Word files
             o   File containing figure legends(s) in .doc format           

PAGE CHARGES

Page charges for this journal are set at $75.00 USD per typeset page.  Nonpayment of page charges may result in a delay in publication.  Costs for printing images in color are a separate fee and are not included in the page charge total.  Contact the Publisher for details.

PREPARATION OF MANUSCRIPT

On the first page of the main text file, provide the title of the article, name(s) of author(s), institutional affiliation(s); and supply a running title of 45-50 characters.  When uploading your article to Manuscript Central, include all authors’ full names (first and last, and middle initial if desired) and contact information.  On the following page, supply a structured abstract of no more than 200 words, stating the aims, results, and conclusions drawn from the study. Reference citations are not permitted in the abstract of an article. The abstract must be followed by the following sections:  Introduction, Materials and Methods, Results, Discussion, Conclusion(s), Acknowledgments, Disclosure, and References. (Results and Discussion must be separate sections.)  Begin each section on a separate page. Number pages consecutively; the first author’s last name should appear on each page. Authors should review the style and clarity of their manuscripts with colleagues before submission.  Please follow the protocol described herein to avoid delay in publication.  Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage.

Authors submitting manuscripts should include names and e-mail addresses of three qualified reviewers who are not collaborators.  However, selection of reviewers is at the discretion of the Editors.

 

Manuscript keywords (search terms): On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines.  These terms may or may not be different from the terms you selected for the peer review process and areas of expertise.  You will be asked to retype these search terms in the submission form when uploading your manuscript.  These keywords will be included in the published article.  If the search terms entered do not match the manuscript, the manuscript will serve as the default.

 

Keywords (Areas of Expertise)

To facilitate the peer review process, select 4-6 keywords from the drop-down list of pre-selected terms when submitting your manuscript.   These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.

Availability of data supporting tables and figures in papers

The Editors of DNA and Cell Biology are requiring the accessibility and transparency of data underlying the results of studies published in this journal. These data should be provided as a supplement(s).

Examples of the types and formats of data follow:

  • Uncropped scans of membranes used for Western blot images, autoradiograms, Southern blots
  • Confocal microscopy stack data files
  • In genome wide association studies (GWAS) all of the findings of unchanged and changed levels of gene expression of all data points acquired for the analysis
  • In clinical trials, links must be included for all data on each subject (encoded to meet HIPAA standards) whether deposited on ClinicalTrials.gov or other sites such as university or consortium servers (e.g., http://yoda.yale.edu/).  If data have not been previously deposited, then the data link at the investigator’s site is acceptable. The NCT number associated with the trial must be included.
  • Accession Number must be provided for each genetic sequence.
  • Digital images of all group members analyzed when a figure is prepared with selected data

DISCLOSURE STATEMENT

Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.”  This text must be part of your manuscript file, not just populated into the system during submission.

In this portion of the manuscript, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the manuscript is being reviewed and will not influence the editorial decision.  Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.  If no conflicts exist, the authors must state “No competing financial interests exist.”

REFERENCES

All references must be cited by authors and dates within the text. For EndnoteTM users, the style is: http://endnote.com/downloads/style/dna-and-cell-biology

e.g. The ribosomal RNA (rrn) operons in E. coli contain single copies of each of the 16S, 23S, and 5S r(RNA) genes (Pace, 1973).

If more than two authors are involved, use et al. after the first author's name.
e.g. (Sogin et al., 1971).

If several works by the same authors are cited in one year, use a lower case letter designation to indicate the individual citations.  e.g. (Dunn and Studier, 1973a, 1973b). Use the same designation in the reference list.

All references in the reference section must be double spaced and listed in alphabetical order at the end of the article. List all authors up to and including six authors. If there are more than six authors, list six and then et al. References must include complete titles and full page range of cited articles.

Journal citation: Pace N. (1973). Structure and synthesis of the ribosomal ribonucleic acid of prokaryotes. Bacteriol Rev 37:562-603.

Book citation: Futuyma DJ. (2005). Evolution, 2nd edition (Sinauer Associates, Sunderland, MA).

Book Chapter citation: Lemon KP, Earl AM, Vlamakis HC, Aguilar C, Kolter R. (2008). Biofilm development with an emphasis on Bacillus subtilis. In Bacterial Biofilms, T. Romero, ed. (Springer, Heidelberg), Chapter 1, pp. 1–16.

Proceedings citation: Lavilla S, González-López JJ, Larrosa MN, Bartolomé RM, Prat G. (2008). Prevalence of the quinolone-modifying enzyme aac(6´)-Ib-cr in extended-spectrum b-lactamase-producing enterobacterial isolates in Barcelona. Abstract no. P1523, presented at the 18th Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, April 19–22.

Abstract citation: Scacheri P, Crabtree J, Kennedy A, Swain G, Ward J, Marx S, Spiegel A, Collins F. (2006). V804 RET mutation in MEN2A: first report. J Int Med 255, 712 (abstract).

Website citation: Los Alamos National Library. (2009). ORALGEN. Available at www.oralgen.lanl.gov. Library LAN ed. (Livermore). Last accessed March 2, 2012.

When dates from an unpublished source are given, supply the researcher's name. If work is in press, give the journal in which it is to be published or the name of the publisher. Abbreviations of journal names should follow the style of Medline.

TABLES AND ILLUSTRATIONS

Prepare each table with a title in a separate files. Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.

All figures should be numbered and a separate file containing figure legends must be supplied for each submitted figure All legends should be numbered consecutively and provided (double spaced).. Figures must be numbered in the order cited in the text.  Images should not show the name of a manufacturer.  Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction.

Electronic submission of art is required as follows:

  • Do not include any illustrations as part of your main text file.

  • Do not prepare any figures in Word as they are not workable.

  • Line illustrations must be submitted at 900 DPI.

  • Halftones and color photos should be submitted at a minimum
    of 300 DPI.

  • Excel files cannot be uploaded.

  • Save art as either TIFF or EPS files. Avoid submitting JPEG, pdf, or .ppt image files.

  • Color art must be saved as CYMK not RGB.

  • When naming your figure files, please name them with the
    main author’s last name, followed by a period (.), and then
    list the figure number. Ex: Smith.Fig1. For Western blots, images should not be overexposed. Partial cropping of bands is allowed, but uncropped images should be included as supplementary data. Positive and negative controls demonstrating antibody specificity should be shown in the main figure or as supplementary data as well as the position of molecular weight markers.

    Supplemental files: Additional figures, tables, and supporting materials, as appropriate should be included in submissions. 

ADDITIONAL INFORMATION ABOUT ART FILES

Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
 
• All files should be scanned at 100% size.
• 300 DPI or greater
• Final color mode: cmyk
• save file as: .tif or .eps
 
If you need directions on how to convert a Power Point slide to acceptable format go to www.liebertpub.com/MEDIA/pdf/ppconvert.pdf

Outstanding color photographs may be chosen for use on the cover, and authors are encouraged to consider this potential when submitting their manuscripts.   

 

IMPORTANT:

Please upload individual files of all manuscript material as outlined in these guidelines—do NOT upload a single PDF file containing all elements of your article. Once all individual files are uploaded to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.


The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.

PERMISSIONS

The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure, should read, "reprinted by permission from Jones et al." and list the appropriate reference. All permissions listings must be shown in the manuscript; they cannot be entered on proofs.

PAGE PROOFS

Page proofs are sent to the corresponding author via e-mail, so please be sure to have any e-mail filters accept e-mail from the liebertpub.com domain.  Please ensure that proper e-mail addresses for all authors are provided.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

ABBREVIATIONS

Rules for abbreviations and nomenclature follow those detailed annually in the first annual issue of J. Biol. Chem.

absorbance..................................................................................A

acetate.....................................................................                     OAc

acetyl.....................................................................                       .Ac

5-bromodeoxyuridine....................................................... .        BrdUrd

O-carboxymethylcellulose.................................................        CM-cellulose

coenzyme A..................................................................               CoA

complementary DNA...........................................................      cDNA

counts per minute...........................................................           cpm

deoxy (carbohydrates and nucleotides).......................................d

deoxyribonuclease...........................................................DNase

diethylaminoethylcellulose..................................................DEAE-cellulose

immunoglobulin..............................................................Ig (IgG, IgM,etc.)

inosine.....................................................................I, Ino

isotopes....................................................................14C, 3H, 32P

nicotinamide-adenine dinucleotide...........................................NAD+, NADH

nicotinamide-adenine dinucleotide phosphate................................ NADP+, NADPH

nicotinamide mononucleotide.................................................NMN

optical density.............................................................OD

phosphate (in compounds)....................................................P or P

phosphate (inorganic).......................................................P1

poly(adenylic acid).........................................................poly(A)

polyadenylated RNA..........................................................poly(A)+RNA

ribonuclease................................................................RNase

ribosomal ribonucleic acid..................................................rRNA

sodium dodecyl sulfate......................................................NaDodSO4

 

Click here to submit your manuscript

Publisher

The Journal is published monthly by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, New Rochelle, NY 10801-5215.  Telephone: (914) 740–2100; Fax: (914) 740–2101; Website:  www.liebertpub.com

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email openaccess@liebertpub.com.

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

 

Valuable benefits of OA available for download.

Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.

 

Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email openaccess@liebertpub.com or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Upcoming Events

Dec 08 - Dec 12, 2018